January 22, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced verification study results for its investigational Nellcor™ pulse oximetry with Nell-EQ™ intelligent processor ...
This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor ...
Covidien has announced the launch of its Nellcor SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform, according to a news release. The Nellcor SpO2 module ...
Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced the integration of its Nellcor™ OxiMax™ oximetry system into Philips IntelliVue and M-Series patient monitors.
Receiving FDA clearance for Nellcor with Nell-EQ could help Medtronic as it competes with Masimo for the pulse oximetry ...
This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor pulse oximetry system with Nell-EQ intelligent processor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results